AXSM (axsome.com) Earnings per share growth rate in current year
Axsome Therapeutics (AXSM) price action depends on the rollout pace of new migraine and depression treatments. The annual EPS growth trajectory demonstrates current profitability, where the value of 30.90 captures the metric level. Business stability is based on the commercialization of patented CNS developments. Strict FDA oversight and long-term intellectual property protection create significant barriers to entry for new players in neuromedicine.
Financial and market metric breakdowns for Axsome Therapeutics (AXSM)
- price and consensus price forecast:
- business market valuation indicators:
- balance sheet equity data:
- debt and solvency information:
All Debt to Shareholders' Equity Ratio Axsome Therapeutics|AXSM - Long-Term Debt to Capital|Current Liabilities to Capital axsome.com|AXSM - Company Debts|Debt to Net Assets Ratio Axsome Corp|AXSM - Company Long-Term Debts|Company Short-Term Debts Axsome Therapeutics|Critical Liquidity Ratio axsome.com
- net income and valuation multiples indicators:
AXSM - Net Profit|Expected Net Profit Axsome Therapeutics|AXSM - Price to Earnings Ratio|Forward P/E Multiple Axsome Corp|AXSM - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Axsome Corp|AXSM - Operating profit EBITDA|Net earnings per share for the last four quarters Axsome Therapeutics|AXSM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months axsome.com|AXSM - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Axsome Therapeutics
Basic company analysis:Axsome (AXSM)
This indicator measures the annual change in earnings per share, allowing investors to differentiate real business expansion from temporary market fluctuations by analyzing capital growth rates. Current year-over-year EPS dynamics confirm the effective scaling of capacities at Axsome Therapeutics (AXSM), whose operating model with contract manufacturers ensures stable drug production without infrastructural disruptions.
Direct competitors
Net earnings per share growth this year Biogen Inc|NBIX (Neurocrine Biosciences Inc) - Earnings growth in current year|Earnings per share growth rate in current year Regencell Corp RGC|Net earnings per share growth this year ACAD (ACADIA Pharmaceuticals)|XENE (xenon-pharma.com) - Earnings per share increase in current year|Viking Therapeutics, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc - Earnings growth in current year|Earnings per share increase in current year DNLI (Denali Corp)|HRMY: Earnings growth in current year|Earnings per share growth rate in current year biohavenpharma.com (BHVN)|Earnings per share growth in current year Amylyx Pharmaceuticals, Inc.|TRVI: Earnings per share increase in current year|Earnings growth in current year PRAX|Earnings growth in current year Anavex Life Sciences Corp (AVXL)|Earnings per share growth in current year CeriBell, Inc. CBLL|PRTA (prothena.com) - Earnings per share trend in current year|Alector Therapeutics - Earnings growth in current year|Earnings per share growth rate in current year Annexon Biosciences|OMER (omeros.com) - Net earnings per share growth this year|Neurogene Therapeutics (NGNE) - Earnings growth in current year|Net earnings per share growth this year ACIU|VYGR (voyagertherapeutics.com) - Net earnings per one share growth for the current year|Earnings growth in current year NMRA|Expected net earnings per share growth this year Scilex Holding|Earnings growth in current year TVGN (Tevogen Bio Holdings, Inc.)|ACOG - Net earnings per share growth this year|CGTX - Earnings per share growth in current year|Expected net earnings per share growth this year inhibikase.com IKT|SAVA: Earnings growth in current year|Assertio (ASRT) - Earnings growth in current year|Net earnings per share growth this year COYA|Earnings per share growth this year VTGN (VistaGen Therapeutics Inc)|Earnings per share growth in current year Ovid Therapeutics Inc. (OVID)|Expected net earnings per share growth this year acumenpharm.com|Earnings per share growth in current year CervoMed CRVO|ATHE - Net earnings per share growth this year|CLNN - Earnings per share growth in current year|PEPG (PepGen Inc.) - Earnings per share growth this year|JUNS: Earnings growth in current year|Earnings per share growth rate in current year relmada.com (RLMD)|Net earnings per share growth this year ANVS|Earnings growth in current year Grace Tx|Earnings per share growth in current year Firefly Neuroscience Inc (AIFF)|KLTO (anewmeds.com) - Earnings per share increase in current year|Earnings per share growth in current year NeuroSense Therapeutics Ltd. NRSN|revivapharma.com (RVPH) - Earnings per share growth rate in current year|MetaVia, Inc. - Earnings growth in current year|NRXS - Earnings growth in current year|HSDT (heliusmedical.com) - Net earnings per share growth this year|Earnings per share growth this year PASG|Earnings per share growth in current year Neuphoria Therapeutics, Inc.|minervaneurosciences.com (NERV) - Expected net earnings per share growth this year|Earnings per share growth in current year Athira Pharma (ATHA)|ADXN - Earnings per share growth rate in current year|Earnings per share growth in current year Alzamend Neuro ALZN|CYCN - Net earnings per share growth this year|Protagenic - Earnings growth in current year|Earnings per share growth rate in current year Pasithea Therapeutics|CRGT (cortigent.com) - Net earnings per share growth this year|Avenue Therapeutics Inc. - Earnings per share increase in current year|Net earnings per share growth this year BCLI|CARA (Cara Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year CHRO|ELYM (eliemtx.com) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|Longboard Pharmaceuticals Inc (LBPH) - Earnings per share growth rate in current year|MRNS - Earnings per share growth in current year|Earnings per share increase in current year NKGN (NKGen Biotech Corp)|NRBO: Earnings growth in current year|sagerx.com (SAGE) - Earnings growth in current year|Earnings per share growth in current year Synaptogenix|Trevena Inc. - Earnings per share trend in current year|Earnings growth in current year VIGL|WENA - Earnings per share growth rate in current year|Cerevel Therapeutics - Net earnings per share growth this year
